FDA: Chantix may carry heart risks
December 13, 2012 (WLS) -- The Federal Drug Administration is warning that the stop-smoking drug Chantix may carry heart risks.
The FDA says as a result, doctors should weigh the risks of the drug against its benefits.
A major review of the drug found slightly higher rates of serious cardiovascular events, including non-fatal heart attacks, non-fatal stroke and cardiovascular-related death.
Experts are quick to point out that the increased risk was not statistically significant. They are asking that smokers talk to their doctors before taking the drug.
- Chicago police officer shot on South Side
- Vietnam says it may have found missing jet's door
- Good Samaritans rescue driver from burning van
- ABC7 First Alert Weather Forecast
- Man fatally shot by police in domestic dispute
- Sheriff Dart facing opposition from own party
- Brown's Chicken killer wins federal lawsuit
- Mobile payment option for metered parking
- Farewell held for local deployed soldiers
- Gay wedding expo celebrates marriage equality
- Fundraiser held for teen injured at ski park
- Orr Academy basketball player among 6 shot at party
- Mexican culture celebrated at Navy Pier
- abcnews: Toddler with Rare Kidney Disease Beats Odds
Most Viewed StoriesMost Viewed Photos